These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6265479

  • 1. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
    Staczek J, Steplewski Z, Weinmann R, Klein G, Koprowski H.
    J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
    Steplewski Z, Koprowski H, Andersson-Anvret M, Klein G.
    J Cell Physiol; 1978 Oct; 97(1):1-8. PubMed ID: 213442
    [Abstract] [Full Text] [Related]

  • 3. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
    Takimoto T, Ogura H, Ohno S, Umeda R, Hatano M.
    J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
    [Abstract] [Full Text] [Related]

  • 4. The difference in tumorigenicity between Epstein-Barr virus (EBV) genome-positive and genome-negative epithelial hybrid cell lines derived from the human nasopharynx.
    Takimoto T, Sato H, Ogura H, Tanaka S, Umeda R.
    Laryngoscope; 1988 Dec; 98(12):1334-8. PubMed ID: 2849005
    [Abstract] [Full Text] [Related]

  • 5. Discordant expression of 2 Epstein-Barr virus-associated antigens, EBNA and RANA, in man-rodent somatic cell hybrids.
    Slovin SF, Glassy MC, Dambaugh T, Catalano MA, Curry RA, Ferrone S, Kieff E, Vaughan JH, Carson DA.
    J Immunol; 1981 Aug; 127(2):585-90. PubMed ID: 6265553
    [Abstract] [Full Text] [Related]

  • 6. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 7. Association of Epstein-Barr virus, human papilloma virus, and cytomegalovirus with nine nasopharyngeal carcinoma cell lines.
    Lin CT, Dee AN, Chen W, Chan WY.
    Lab Invest; 1994 Nov; 71(5):731-6. PubMed ID: 7967524
    [Abstract] [Full Text] [Related]

  • 8. Detection of Epstein-Barr virus DNA and HHV-6 DNA in tissue biopsies from patients with nasopharyngeal carcinoma by polymerase chain reaction.
    Kositanont U, Kondo K, Chongkolwatana C, Metheetrairut C, Puthavathana P, Chantarakul N, Wasi C, Yamanishi K.
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):455-60. PubMed ID: 8160052
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
    Sato H, Takimoto T, Ogura H, Tanaka J, Hatano M, Glaser R.
    J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
    [Abstract] [Full Text] [Related]

  • 10. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.
    Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS.
    Oncogene; 1992 Nov; 7(11):2131-40. PubMed ID: 1331932
    [Abstract] [Full Text] [Related]

  • 11. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A, Taquia E, Vockerodt M, Draube A, Pawlita M, Möller P, Bullerdiek J, Diehl V, Wolf J.
    Cancer Res; 1998 Nov 01; 58(21):4930-9. PubMed ID: 9810002
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
    Wang L, Shan L, Lo KW, Yin J, Zhang Y, Sun R, Zhong J.
    J Gene Med; 2008 Oct 01; 10(10):1124-33. PubMed ID: 18642396
    [Abstract] [Full Text] [Related]

  • 13. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo.
    Sheu LF, Chen A, Meng CL, Ho KC, Lee WH, Leu FJ, Chao CF.
    J Pathol; 1996 Nov 01; 180(3):243-8. PubMed ID: 8958799
    [Abstract] [Full Text] [Related]

  • 14. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
    Fåhraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P.
    Int J Cancer; 1988 Sep 15; 42(3):329-38. PubMed ID: 2843473
    [Abstract] [Full Text] [Related]

  • 15. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
    Tan RS, Li JS, Grill SP, Nutter LM, Cheng YC.
    Cancer Res; 1986 Oct 15; 46(10):5024-8. PubMed ID: 3019519
    [Abstract] [Full Text] [Related]

  • 16. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT, Lin CR, Tan GK, Chen W, Dee AN, Chan WY.
    Am J Pathol; 1997 May 15; 150(5):1745-56. PubMed ID: 9137098
    [Abstract] [Full Text] [Related]

  • 17. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines.
    Lin CT, Chen W, Hsu MM, Dee AN.
    Lab Invest; 1997 Jun 15; 76(6):793-8. PubMed ID: 9194855
    [Abstract] [Full Text] [Related]

  • 18. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity.
    Seto E, Ooka T, Middeldorp J, Takada K.
    Cancer Res; 2008 Feb 15; 68(4):1030-6. PubMed ID: 18281477
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line.
    Yoshizaki T, Takimoto T, Takeshita H, Tanaka S, Furukawa M, Seiki M, Sato H.
    Laryngoscope; 1994 Jan 15; 104(1 Pt 1):91-4. PubMed ID: 8295464
    [Abstract] [Full Text] [Related]

  • 20. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma.
    Takimoto T, Umeda R.
    Acta Virol; 1989 Aug 15; 33(4):314-9. PubMed ID: 2574937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.